Novartis AG Increase Decrease In Cash And Cash Equivalents Discontinued Operations
Novartis AG (NVSEF) reported Increase Decrease In Cash And Cash Equivalents Discontinued Operations of $499.00 million for the 3-month period ending 2019-06-30, per its 6-K filed 2020-07-21.
Discontinued › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations · last filed 2020-07-21
- Novartis AG increase decrease in cash and cash equivalents discontinued operations for the quarter ending 2019-06-30 was $499.00M.
| Period end | Increase Decrease In Cash And Cash Equivalents Discontinued Operations 3 month |
|---|---|
| 2019-06-30 | $499.00M 6-K · filed 2020-07-21 |